Farms.com Home   News

Governments of Canada and Manitoba invest $680,900 in two projects to protect animal health and ensure international competitiveness of Manitoba pork industry

Winnipeg, Manitoba – Agriculture and Agri-Food Canada - The governments of Canada and Manitoba are investing $680,900 under the Canadian Agricultural Partnership to support two major projects aimed at protecting animal health and managing disease in the provincial pork industry, federal Member of Parliament for Winnipeg South Terry Duguid and Manitoba Agriculture Minister Derek Johnson announced today.

The Invasive Swine Eradication Initiative Project will help mitigate the threat of disease spread by invasive pigs, particularly the highly contagious African Swine Fever (ASF), to commercial herds by seeking out, corralling and euthanizing invasive swine, thereby protecting herd health and the province’s natural resources.

Manitoba is developing a draft strategy for invasive swine management and will seek feedback from industry, interest groups and the public.

The Manitoba High Traffic Facility Swine Disease Surveillance Project is a continuation of the governments’ efforts to address the risk of porcine epidemic diarrhea (PED) over the past seven years. It will allow more time to fully evaluate mitigation efforts taken by the swine sector that have decreased the occurrence of PED.

Both projects contribute to a strong foundation to managing risk, which is important in building industry resilience to support the objectives of the Manitoba Protein Advantage Strategy.

Source : canada

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.